Evidence map›Paper›PMID 36077715›Full record

ArticleCancers2022

Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions.

Radhika Manukonda, Vengala Rao Yenuganti, Nupur Nagar, Pankaj Singh Dholaniya, Shivani Malpotra, Jyothi Attem, Mamatha M Reddy, Saumya Jakati, Dilip K Mishra, Pallu Reddanna and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Radhika ManukondaThe Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad 500034, India.
Vengala Rao YenugantiDepartment of Animal Biology, School of Life Sciences, University of Hyderabad, Prof. C.R. Rao Road, Gachibowli, Hyderabad 500046, India.
Nupur NagarDepartment of Biosciences and Bioengineering, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Pankaj Singh DholaniyaDepartment of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Prof. C.R. Rao Road, Gachibowli, Hyderabad 500046, India.ORCID 0000-0001-8615-9861
Shivani MalpotraThe Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad 500034, India.ORCID 0000-0003-3524-4219
Jyothi AttemSchool of Medical Sciences, Science Complex, University of Hyderabad, Prof. C.R. Rao Road, Gachibowli, Hyderabad 500046, India.
Mamatha M ReddyThe Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar 751024, India.ORCID 0000-0002-3492-4661
Saumya JakatiOphthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad 500034, India.ORCID 0000-0002-3365-2588
Dilip K MishraOphthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad 500034, India.
Pallu ReddannaDepartment of Animal Biology, School of Life Sciences, University of Hyderabad, Prof. C.R. Rao Road, Gachibowli, Hyderabad 500046, India.
Krishna Mohan PoluriDepartment of Biosciences and Bioengineering, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, India.ORCID 0000-0003-3801-7134
Geeta K VemugantiSchool of Medical Sciences, Science Complex, University of Hyderabad, Prof. C.R. Rao Road, Gachibowli, Hyderabad 500046, India.
Swathi KalikiThe Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad 500034, India.ORCID 0000-0002-0800-9961
L V Prasad Eye Institute · INUniversity of Hyderabad · INIndian Institute of Technology Roorkee · IN

Funding

Science and Engineering Research Board CRG/2018/004122
6 · The paper itself

Abstract

The present study employed nanoparticle tracking analysis, transmission electron microscopy, immunoblotting, RNA sequencing, and quantitative real-time PCR validation to characterize serum-derived small extracellular vesicles (sEVs) from RB patients and age-matched controls. Bioinformatics methods were used to analyze functions, and regulatory interactions between coding and non-coding (nc) sEVs RNAs. The results revealed that the isolated sEVs are round-shaped with a size < 150 nm, 5.3 × 1011 ± 8.1 particles/mL, and zeta potential of 11.1 to −15.8 mV, and expressed exosome markers CD9, CD81, and TSG101. A total of 6514 differentially expressed (DE) mRNAs, 123 DE miRNAs, and 3634 DE lncRNAs were detected. Both miRNA-mRNA and lncRNA-miRNA-mRNA network analysis revealed that the cell cycle-specific genes including CDKNI1A, CCND1, c-MYC, and HIF1A are regulated by hub ncRNAs MALAT1, AFAP1-AS1, miR145, 101, and 16-5p. Protein-protein interaction network analysis showed that eye-related DE mRNAs are involved in rod cell differentiation, cone cell development, and retinol metabolism. In conclusion, our study provides a comprehensive overview of the RB sEV RNAs and regulatory interactions between them.

Indexed as

exosomesextracellular vesiclesliquid biopsylong non-coding RNAmicroRNAretinoblastomaRNA seq

Identifiers

PMID36077715
PMCPMC9454787
OpenAlexW4293526309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.